Inhibition	NN
of	IN
mechanosensitive	JJ
signaling	NN
in	IN
myofibroblasts	NNS
ameliorates	VBZ
experimental	JJ
pulmonary	JJ
fibrosis	NN
.	.

Matrix	NNP
stiffening	VBG
and	CC
myofibroblast	NN
resistance	NN
to	TO
apoptosis	NN
are	VBP
cardinal	JJ
features	NNS
of	IN
chronic	JJ
fibrotic	JJ
diseases	NNS
involving	VBG
diverse	JJ
organ	NN
systems	NNS
.	.

The	DT
interactions	NNS
between	IN
altered	JJ
tissue	NN
biomechanics	NNS
and	CC
cellular	JJ
signaling	NN
that	WDT
sustain	VBP
progressive	JJ
fibrosis	NN
are	VBP
not	RB
well	RB
defined	VBN
.	.

In	IN
this	DT
study	NN
,	,
we	PRP
used	VBD
ex	FW
vivo	FW
and	CC
in	FW
vivo	FW
approaches	NNS
to	TO
define	VB
a	DT
mechanotransduction	NN
pathway	NN
involving	VBG
Rho/Rho	NN
kinase	NN
(	(
Rho/ROCK	NN
)	)
,	,
actin	NN
cytoskeletal	JJ
remodeling	NN
,	,
and	CC
a	DT
mechanosensitive	JJ
transcription	NN
factor	NN
,	,
megakaryoblastic-leukemia-1	NN
(	(
MKL1	NN
)	)
,	,
that	WDT
coordinately	RB
regulate	VBP
myofibroblast	NN
differentiation	NN
and	CC
survival	NN
.	.

Both	CC
in	IN
an	DT
experimental	JJ
mouse	NN
model	NN
of	IN
lung	NN
fibrosis	NN
and	CC
in	IN
human	JJ
subjects	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
,	,
we	PRP
observed	VBD
activation	NN
of	IN
the	DT
Rho/ROCK	NN
pathway	NN
,	,
enhanced	VBD
actin	NN
cytoskeletal	JJ
polymerization	NN
,	,
and	CC
MKL1	NN
cytoplasmic-nuclear	JJ
shuttling	NN
.	.

Pharmacologic	JJ
disruption	NN
of	IN
this	DT
mechanotransduction	NN
pathway	NN
with	IN
the	DT
ROCK	NN
inhibitor	NN
fasudil	NN
induced	VBD
myofibroblast	JJ
apoptosis	NN
through	IN
a	DT
mechanism	NN
involving	VBG
downregulation	NN
of	IN
BCL-2	NN
and	CC
activation	NN
of	IN
the	DT
intrinsic	JJ
mitochondrial	JJ
apoptotic	JJ
pathway	NN
.	.

Treatment	NN
with	IN
fasudil	NN
during	IN
the	DT
postinflammatory	JJ
fibrotic	JJ
phase	NN
of	IN
lung	NN
injury	NN
or	CC
genetic	JJ
ablation	NN
of	IN
Mkl1	NN
protected	VBD
mice	NNS
from	IN
experimental	JJ
lung	NN
fibrosis	NN
.	.

These	DT
studies	NNS
indicate	VBP
that	IN
targeting	VBG
mechanosensitive	JJ
signaling	NN
in	IN
myofibroblasts	NNS
to	TO
trigger	VB
the	DT
intrinsic	JJ
apoptosis	NN
pathway	NN
may	MD
be	VB
an	DT
effective	JJ
approach	NN
for	IN
treatment	NN
of	IN
fibrotic	JJ
disorders	NNS
.	.

